1. SRChing for the substrates of Src.
- Author
-
Reynolds AB, Kanner SB, Bouton AH, Schaller MD, Weed SA, Flynn DC, and Parsons JT
- Subjects
- Animals, Catenins physiology, Cell Transformation, Neoplastic, Cortactin physiology, Crk-Associated Substrate Protein physiology, Focal Adhesion Kinase 1 physiology, Humans, Mice, Microfilament Proteins physiology, Phosphorylation, Proteome, Delta Catenin, Gene Expression Regulation, Neoplastic, Neoplasms metabolism, src-Family Kinases metabolism
- Abstract
By the mid 1980's, it was clear that the transforming activity of oncogenic Src was linked to the activity of its tyrosine kinase domain and attention turned to identifying substrates, the putative next level of control in the pathway to transformation. Among the first to recognize the potential of phosphotyrosine-specific antibodies, Parsons and colleagues launched a risky shotgun-based approach that led ultimately to the cDNA cloning and functional characterization of many of today's best-known Src substrates (for example, p85-Cortactin, p110-AFAP1, p130Cas, p125FAK and p120-catenin). Two decades and over 6000 citations later, the original goals of the project may be seen as secondary to the enormous impact of these protein substrates in many areas of biology. At the request of the editors, this review is not restricted to the current status of the substrates, but reflects also on the anatomy of the project itself and some of the challenges and decisions encountered along the way.
- Published
- 2014
- Full Text
- View/download PDF